Skip to content

Drug interactions

Clobazam + Lorlatinib

Severity: Moderate

Clobazam and Lorlatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Clobazam is a weak to moderate CYP3A4 inducer and may lower lorlatinib exposure, potentially reducing antitumor efficacy. Lorlatinib is itself associated with hepatotoxicity and induction-related changes in liver enzymes, so the combination needs attention.

What this interaction means in plain words

Clobazam and Lorlatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clobazam belongs to Central Nervous System; Lorlatinib belongs to Oncology.

Evidence level: Low

Why it happens

Clobazam induces CYP3A4, increasing the metabolism of lorlatinib.

What to do

Prefer an alternative anticonvulsant or anxiolytic if feasible. If the combination is needed, monitor ALT, AST and bilirubin and watch for loss of lorlatinib response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clobazam and Lorlatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Clobazam with Lorlatinib?

MediHelp rates the interaction as moderate. Clobazam and Lorlatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Clobazam is a weak to moderate CYP3A4 inducer and may lower lorlatinib exposure, potentially reducing antitumor efficacy. Lorlatinib is itself associated with hepatotoxicity and induction-related changes in liver enzymes, so the combination needs attention.

How serious is the interaction between Clobazam and Lorlatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative anticonvulsant or anxiolytic if feasible. If the combination is needed, monitor ALT, AST and bilirubin and watch for loss of lorlatinib response.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in